Repurposed antiviral drug candidate with a well‑established safety profile for prevention and treatment of dengue and other mosquito‑borne viral diseases. Development strategy leverages existing clinical data to accelerate development, reduce clinical risk, and serve patients in regions with limited therapeutic options.